Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 13 results

Ranking

Release Date Sort Sort Article Type

Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity

Nashwa Ismail Hashaad, Rasha Mohamed Fawzy, Abeer Ahmed Abo Elazem, Mohamed Ibrahim Youssef

(Eur J Rheumatol 2017; 4: 19-23) DOI: 10.5152/eurjrheum.2017.160071

Abstract Full Text (PDF) Related Articles

The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis

Martin Lee, John Isaacs

(Eur J Rheumatol 2017; 4: 68-69) DOI: 10.5152/eurjrheum.2016.055

Abstract Full Text (PDF) Related Articles

Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept

Ariane Klein, Harald Reinhard, Annette M. Mueller, Gerd Horneff

(Eur J Rheumatol 2017; 4: 136-138) DOI: 10.5152/eurjrheum.2016.032

Abstract Full Text (PDF) Related Articles

Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity

The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis

Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept

Serological screening for celiac disease in children with systemic lupus erythematosus

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Musculoskeletal ultrasound in children: Current state and future directions

Pediatric Behçet’s disease - clinical aspects and current concepts

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Evaluation of enthesitis in patients with juvenile idiopathic arthritis by power color and spectral Doppler ultrasonography

Juvenile spondyloartropathies

Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases

Ultrasound in pediatric rheumatology: Highlighting the differences with adults

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis